Ventilator-associated pneumonia (VAP) and healthcare-associated pneumonia (HAP)

This page is in the process of being updated

AGENCIES

US Centers for Disease Control and Prevention (CDC)

• Guidelines for Preventing Health-care-associated Pneumonia (2003)

PROFESSIONAL SOCIETIES

American Thoracic Society (ATS) / Infectious Diseases Society of America (IDSA)

• Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia (2005)

British Society of Antimicrobial Chemotherapy (BSAC)

• Guidelines for the management of hospital-acquired pneumonia in the UK. Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy (2008)

Society of Healthcare Epidemiology of America (SHEA)

• Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update (SHEA, 2022).

EU/EEA COUNTRIES

GERMANY

• Prevention of nosocomial pneumonia (Robert Koch Institute, 2000)
  Prävention der nosokomialen Pneumonie (Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut, 2000)

HUNGARY

• Prevention of nosocomial pneumonia (National Centre for Epidemiology, 2002)
  A nosocomiális pneumónia megelőzése (Országos Epidemiológiai Központ, 2002)

IRELAND

• Guidelines for the prevention of ventilator-associated pneumonia in adults in Ireland (Health Protection Surveillance Centre - SARI Working Group, 2011)